The drugs are listed in alphabetical order. Aprepitant oral suspension: Merck reported a shortage of Emend, its aprepitant oral suspension. Merck did not provide a reason for the shortage. The ...
DIsney says it has sold out all commercial inventory for Sunday's Oscars, and notes packages include TV, streaming, social ...
Bizcommunity.com on MSN10d
Oscars reach unprecedented demand with sold-out ads and A-list sponsorsThe demand for this year’s Oscars is an undeniable reflection of the show’s evergreen cultural influence, and a testament to ...
Skylar Clarine is a fact-checker and expert in personal finance with a range of experience including veterinary technology and film studies ... pharmaceutical company Sanofi's (SNY) acquisition ...
Our weekly roundup of the latest appointments and account wins news from 1702 Digital, Communicate India, Mad Influence, NP ...
Sanofi and Johnson & Johnson ended development of an experimental vaccine after it failed to adequately protect against an invasive form of the digestive pathogen E. coli. Sanofi recorded a $250 ...
Sanofi SA (NASDAQ:SNY) and Johnson & Johnson (NYSE:JNJ) have discontinued the E.mbrace phase 3 study evaluating a vaccine candidate for extraintestinal pathogenic E. coli. The E.mbrace study is a ...
Sanofi and Regeneron’s blockbuster biologic Dupixent (dupilumab) is poised for yet another label expansion, this time for the rare autoimmune skin disorder bullous pemphigoid (BP). The US Food ...
Sanofi SA (NASDAQ:SNY) and Johnson & Johnson (NYSE:JNJ) have discontinued the E.mbrace phase 3 study evaluating a vaccine candidate for extraintestinal pathogenic E. coli. The E.mbrace study is a ...
Sanofi (NASDAQ:SNY) said on Thursday that it is discontinuing the late-stage trial for its vaccine to prevent E. coli bacteria infection as it failed to demonstrate sufficient efficacy. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback